A 'bird's eye' view on the current status and potential benefits of blood biomarkers for Parkinson's disease

Biomark Med. 2014;8(2):225-7. doi: 10.2217/bmm.13.139.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / blood*
  • Biomarkers / cerebrospinal fluid
  • Disease Progression
  • Epidermal Growth Factor / blood
  • Humans
  • Parkinson Disease / blood
  • Parkinson Disease / diagnosis*
  • Parkinson Disease / metabolism
  • alpha-Synuclein / blood
  • alpha-Synuclein / cerebrospinal fluid

Substances

  • Biomarkers
  • alpha-Synuclein
  • Epidermal Growth Factor